D-Street Buzz: Pharma stocks gain led by Sun Pharma; Titan spikes 4%, RIL most active

The Indian benchmark indices continued to hold steady with the Nifty50 jumping 100 points, trading at 10,879 while the Sensex zoomed 343 points and was trading at 36,148.

Nifty Pharma added over 1.5 percent led by gains from Sun Pharma which spiked close to 4 percent followed by Dr Reddy’s Labs, Piramal Enterprises and Cadila Healthcare.

From the media space, the top gainers were Network 18 which jumped 5 percent followed by Zee Entertainment, Sun TV Network, International EROS and DB Corp.

Midcap stocks were also buzzing led by NBCC, PAGE Industries, Power Finance, REC, Reliance Infra, Reliance Power, Apollo Tyres, Balkrishna Industries, Bharat Forge, Godrej Industries, JSPL, Jubilant Foodworks and Muthoot Finance among others.

The top gainers from NSE include Sun Pharma, Zee Entertainment, IOC, Titan Company and YES Bank while the top losers included Bharti Infratel, Coal India, Asian Paints, Bajaj Auto and Hero Moto.
The most active stocks were Reliance Industries, Titan Company, YES Bank, HDFC Bank and Sun Pharma.

Bata India, Commercial Engineers & Body Builders, Proseed India and SPL Industries have hit new 52-week high on NSE in this afternoon session.43 stocks have hit new 52-week low including names like Adhunik Metaliks, California Software, Mcnally Bharat Engineering, Ortel Communications, Shilpi Cable and Visesh Infotecnics among others.
The breadth of the market favoured the advances with 1151 stocks advancing and 520 declining while 392 remained unchanged. On the BSE, 1551 stocks advanced, 945 declined and 152 remained unchanged.

Disclosure: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

  • Related Posts

    • Pharma
    • March 27, 2024
    • 96 views
    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

    • Pharma
    • March 27, 2024
    • 66 views
    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

    Lee Health develops natural capsule for effective Heart care

    Lee Health develops natural capsule for effective Heart care

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

    Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down